Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Topotecan × Clear all

Sponsor

Conditions

Ovarian Neoplasms 22 Small Cell Lung Carcinoma 20 Neuroblastoma 12 Fallopian Tube Neoplasms 10 Uterine Cervical Neoplasms 8 Carcinoma, Ovarian Epithelial 7 Lung Neoplasms 5 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Leukemia, Myeloid, Acute 3 Ganglioneuroblastoma 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Retinoblastoma 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

fludarabine phosphate 20 Mycophenolic Acid 15 Whole-Body Irradiation 14 Peripheral Blood Stem Cell Transplantation 11 Cyclophosphamide 11 Cyclosporine 10 Cyclosporins 8 fludarabine 7 Tacrolimus 7 Rituximab 7 Antilymphocyte Serum 7 Busulfan 6 Sirolimus 4 Melphalan 4 Methotrexate 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Filgrastim 2 Etoposide 2 Darbepoetin alfa 2 thymoglobulin 1 selinexor 1 ofatumumab 1 immunotoxin HA22 1 ferrous sulfate 1 ferric gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡